These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29395424)

  • 1. Rationale and design of the Clinical and Histologic Analysis of Mesenchymal Stromal Cells in AmPutations (CHAMP) trial investigating the therapeutic mechanism of mesenchymal stromal cells in the treatment of critical limb ischemia.
    Wang SK; Green LA; Drucker NA; Motaganahalli RL; Fajardo A; Murphy MP
    J Vasc Surg; 2018 Jul; 68(1):176-181.e1. PubMed ID: 29395424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the SAIL trial for intramuscular injection of allogeneic mesenchymal stromal cells in no-option critical limb ischemia.
    Wijnand JGJ; Teraa M; Gremmels H; van Rhijn-Brouwer FCC; de Borst GJ; Verhaar MC;
    J Vasc Surg; 2018 Feb; 67(2):656-661. PubMed ID: 29242062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia.
    Wang SK; Green LA; Motaganahalli RL; Wilson MG; Fajardo A; Murphy MP
    J Vasc Surg; 2017 Jun; 65(6):1850-1857.e2. PubMed ID: 28390770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies.
    Rigato M; Monami M; Fadini GP
    Circ Res; 2017 Apr; 120(8):1326-1340. PubMed ID: 28096194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethnic minorities with critical limb ischemia derive equal amputation risk reduction from autologous cell therapy compared with whites.
    Wang SK; Green LA; Gutwein AR; Drucker NA; Babbey CM; Gupta AK; Fajardo A; Motaganahalli RL; Wilson MG; Murphy MP
    J Vasc Surg; 2018 Aug; 68(2):560-566. PubMed ID: 29503004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of transcutaneous oxygen tension and ankle-brachial index as predictors of reoperation following below-knee amputation.
    Braet DJ; Pourak K; Delbono L; Powell C; Smith ME; Schechtman D; Obi AT; Coleman DM; Corriere MA
    J Vasc Surg; 2024 Jul; 80(1):223-231.e2. PubMed ID: 38431062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous bone marrow mesenchymal stromal cell therapy for "no-option" critical limb ischemia is limited by karyotype abnormalities.
    Mohamed SA; Howard L; McInerney V; Hayat A; Krawczyk J; Naughton S; Finnerty A; Holohan M; Duffy A; Moloney T; Kavanagh E; Burke P; Liew A; Tubassam M; Walsh SR; O'Brien T
    Cytotherapy; 2020 Jun; 22(6):313-321. PubMed ID: 32273232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE Trial.
    Norgren L; Weiss N; Nikol S; Hinchliffe RJ; Lantis JC; Patel MR; Reinecke H; Ofir R; Rosen Y; Peres D; Aberman Z
    Eur J Vasc Endovasc Surg; 2019 Apr; 57(4):538-545. PubMed ID: 30686676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous bone marrow mononuclear cell implantation therapy is an effective limb salvage strategy for patients with severe peripheral arterial disease.
    Franz RW; Shah KJ; Pin RH; Hankins T; Hartman JF; Wright ML
    J Vasc Surg; 2015 Sep; 62(3):673-80. PubMed ID: 26304481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion and angiogenic potential of mesenchymal stem cells from patients with critical limb ischemia.
    Brewster L; Robinson S; Wang R; Griffiths S; Li H; Peister A; Copland I; McDevitt T
    J Vasc Surg; 2017 Mar; 65(3):826-838.e1. PubMed ID: 26921003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia.
    Powell RJ; Comerota AJ; Berceli SA; Guzman R; Henry TD; Tzeng E; Velazquez O; Marston WA; Bartel RL; Longcore A; Stern T; Watling S
    J Vasc Surg; 2011 Oct; 54(4):1032-41. PubMed ID: 21684715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia.
    Kinoshita M; Fujita Y; Katayama M; Baba R; Shibakawa M; Yoshikawa K; Katakami N; Furukawa Y; Tsukie T; Nagano T; Kurimoto Y; Yamasaki K; Handa N; Okada Y; Kuronaka K; Nagata Y; Matsubara Y; Fukushima M; Asahara T; Kawamoto A
    Atherosclerosis; 2012 Oct; 224(2):440-5. PubMed ID: 22877866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone Marrow derived Cell Therapy in Critical Limb Ischemia: A Meta-analysis of Randomized Placebo Controlled Trials.
    Peeters Weem SM; Teraa M; de Borst GJ; Verhaar MC; Moll FL
    Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):775-83. PubMed ID: 26460286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current accepted hemodynamic criteria for critical limb ischemia do not accurately stratify patients at high risk for limb loss.
    Vallabhaneni R; Kalbaugh CA; Kouri A; Farber MA; Marston WA
    J Vasc Surg; 2016 Jan; 63(1):105-12. PubMed ID: 26412436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety and Therapeutic Efficacy of Angiogenesis Induced by Intraarterial Autologous Bone Marrow-Derived Stem Cells in Patients with Severe Peripheral Arterial Disease.
    Sharma S; Pandey NN; Sinha M; Kumar S; Jagia P; Gulati GS; Gond K; Mohanty S; Bhargava B
    J Vasc Interv Radiol; 2021 Feb; 32(2):157-163. PubMed ID: 33248918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alginate-Encapsulated Mesenchymal Stromal Cells Improve Hind Limb Ischemia in a Translational Swine Model.
    Deppen JN; Ginn SC; Tang EO; Wang L; Brockman ML; Levit RD
    J Am Heart Assoc; 2024 May; 13(9):e029880. PubMed ID: 38639336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Below-Knee Amputation Failure and Poor Functional Outcomes Are Higher Than Predicted in Contemporary Practice.
    Columbo JA; Nolan BW; Stucke RS; Rzucidlo EM; Walker KL; Powell RJ; Suckow BD; Stone DH
    Vasc Endovascular Surg; 2016 Nov; 50(8):554-558. PubMed ID: 27909207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes does not worsen outcomes following infrageniculate bypass or endovascular intervention for patients with critical limb ischemia.
    Hicks CW; Najafian A; Farber A; Menard MT; Malas MB; Black JH; Abularrage CJ
    J Vasc Surg; 2016 Dec; 64(6):1667-1674.e1. PubMed ID: 27871493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow aspirate injection for treatment of critical limb ischemia with comparison to patients undergoing high-risk bypass grafts.
    Giles KA; Rzucidlo EM; Goodney PP; Walsh DB; Powell RJ
    J Vasc Surg; 2015 Jan; 61(1):134-7. PubMed ID: 25086735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification in patients with no-option chronic limb-threatening ischemia.
    van Haelst STW; Teraa M; Moll FL; de Borst GJ; Verhaar MC; Conte MS
    J Vasc Surg; 2018 Oct; 68(4):1104-1113.e1. PubMed ID: 29802042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.